Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. J. Lindsey AlleyMD & CFO | -7,10k | 0,00 | Other Disposition | - | 81,57k | -8,01% |
| 2026-05-21 | Mr. Scott Lee BeiserCo-Chairman & Director | -6,27k | 941,38k | Derivative Exercise and Sale | 150,26 | 0,00 | - |
| 2026-05-15 | Mr. Paul Eric SiegertCo-Chairman, Global Co-Head of Financial Restructuring & Director | -9,36k | 1,41M | Sale to Issuer | 150,35 | 375,30k | -2,43% |
| 2026-05-19 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -2,11k | 316,79k | Sale to Issuer | 150,35 | 49,13k | -4,11% |
| 2026-05-15 | Mr. Todd John CarterMD & Director | -13,71k | 2,06M | Sale to Issuer | 150,35 | 76,20k | -15,25% |
| 2026-05-15 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -4,62k | 694,47k | Sale to Issuer | 150,35 | 1,06M | -0,43% |
| 2026-05-15 | Mr. Scott Lee BeiserCo-Chairman & Director | -6,50k | 976,82k | Sale to Issuer | 150,35 | 793,92k | -0,81% |
| 2026-05-15 | Mr. J. Lindsey AlleyMD & CFO | -2,98k | 448,49k | Sale to Issuer | 150,35 | 67,37k | -4,24% |
| 2026-05-15 | Mr. Scott Joseph AdelsonCEO & Director | -11,09k | 1,67M | Sale to Issuer | 150,35 | 867,83k | -1,26% |
| 2026-04-01 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -500,00 | 71,70k | Derivative Exercise and Sale | 143,40 | 0,00 | - |
| 2026-02-06 | Mr. Robert A. SchriesheimLead Independent Director | -5,00k | 854,30k | Vente | 170,86 | 27,98k | -15,16% |
| 2026-01-02 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -500,00 | 87,09k | Derivative Exercise and Sale | 174,17 | 0,00 | - |
| 2025-12-05 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -5,00k | 0,00 | Derivative Exercise and Sale | - | 0,00 | - |
| 2025-11-26 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -1,20k | 0,00 | Derivative Exercise and Sale | - | - | - |
| 2025-11-10 | Mr. Scott Lee BeiserCo-Chairman & Director | -8,00k | 0,00 | Derivative Exercise and Sale | - | 0,00 | - |
| 2025-09-16 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -6,81k | 1,38M | Derivative Exercise and Sale | 202,75 | 0,00 | - |
| 2025-09-02 | Mr. Christopher M. CrainMD, General Counsel & Secretary | -500,00 | 98,11k | Derivative Exercise and Sale | 196,22 | 0,00 | - |
| 2025-08-27 | Mr. Paul Eric SiegertCo-Chairman, Global Co-Head of Financial Restructuring & Director | -40,00k | 8,00M | Derivative Exercise and Sale | 199,95 | 0,00 | - |
| 2025-08-05 | Mr. Scott Joseph AdelsonCEO & Director | -114,40k | 0,00 | Other Disposition | - | 993,32k | -10,33% |
| 2025-07-18 | Mr. Paul Eric SiegertCo-Chairman, Global Co-Head of Financial Restructuring & Director | -2,82k | 0,00 | Other Disposition | - | 427,48k | -0,65% |
| 2025-07-14 | Ms. Gillian Beth ZuckerIndependent Director | -200,00 | 38,33k | Automatic Disposition | 191,65 | 5,53k | -3,49% |
| 2025-06-30 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -5,00k | 914,05k | Derivative Exercise and Sale | 182,81 | 0,00 | - |
| 2025-06-24 | Mr. Irwin N. GoldCo-Chairman & Chairman of the Board | -5,00k | 0,00 | Derivative Exercise and Sale | - | 0,00 | - |
| 2025-06-13 | Ms. Gillian Beth ZuckerIndependent Director | -200,00 | 34,87k | Automatic Disposition | 174,37 | 5,73k | -3,37% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
